Navigation Links
The Noblis Center for Health Innovation Forecasts 2009 Trends In Provider Health Care Delivery
Date:12/3/2008

FALLS CHURCH, Va., Dec. 3/PRNewswire/ -- With access to capital becoming more restricted accompanied by a significant decline in philanthropic giving, dwindling investment income, increasing bad debt and growing charity care, many hospitals and health systems are extremely vulnerable.

In the wake of the current economic crisis, here are the five most significant issues that will impact provider health care delivery in 2009, as predicted by the Noblis Center for Health Innovation, a leading non-profit advisory firm to health providers:

    1. Consumer demands will continue to change

       -- Healthcare utilization will be stable or even decline as consumers
          delay in seeking routine care.
       -- Consumers will continue to seek medical information/knowledge via
          Web resources.
       -- Medical travel will increase, expanding the competitive environment.

    2. Budgets will be trimmed and capital investments delayed

       -- Margins will decline, negatively affecting investment income,
          philanthropy, interest payments, unemployment, cash flow, bad debt,
          and charity care.
       -- The economic downturn will force most hospitals to trim their
          operating budgets in 2009, resulting in hiring freezes of
          non-clinical staff, lay-offs, and other expense reductions.
       -- The credit market will tighten further and bond ratings will fall,
          limiting hospitals ability to access capital.
       -- The recent health care construction boom will continue, but at a
          much slower rate.

    3. The health care industry will consolidate even further

       -- Hospitals that have historically relied on investment income,
          municipal funding of indigent and charity care, and low interest
          rate credit lines will experience an increase in bankruptcies,
          program closures, and/or hospital closures.

'/>"/>
SOURCE Noblis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education
2. UCSF Medical Center Leads Nation in ER Heart Attack Care
3. Condell Health Network and Medical Center to Pay $36 Million Settlement After Self-Reporting Possible Health-Care Fraud
4. NHS Human Services to Take Over Tri County Human Services Center
5. Saint Barnabas Medical Center Pioneers New Program Bringing Humanities and Humanism to Medicine
6. Acuo Technologies Announces Vendor Neutral Archiving Contract With Rush University Medical Center
7. Fox Chase Cancer Center Purchases CyberKnife System
8. PA Department of Health Halts Admissions at Commonwealth Medical Center in Beaver County
9. VA and Louisiana State University Announce Site Selections for New Orleans Medical Center Projects
10. Design Firm Taps Into Veterans Subconscious to Aid in Designing First-of-its- Kind Recovery Center
11. CVS/pharmacy Raising Funds for the St. Jude Childrens Research Hospital(R) Thanks and Giving(R) Campaign to Support Expanded Rehabilitation Services Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... July 26, 2014 According to the ... this is a comprehensive bodybuilding program that helps men ... anabolic steroids . The program also instructs men ... cardio. , Vkool reveals in its review that ... that can help men get ripped and jacked at ...
(Date:7/26/2014)... As the category creator and world leader ... Xoçai is to transform and improve individual ... products. One such unique element is XoVita™, a ... blueberries, an ingredient combination exclusive to Xoçai. This ... all of Xoçai products and provides a wide-ranging ...
(Date:7/25/2014)... 2014 PersonalInjurySolicitorsIreland, a legal claims ... people who have suffered from a variety of ... their new company, and a website, http://www.PersonalInjurySolicitorsIreland.com ... website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the law firm ... the company is always on the client, and ...
(Date:7/25/2014)... In recent years, men have become more aware ... symptoms associated with age-related testosterone decline. Amid concerns about testosterone ... case study from Renew Man helps to shed ... using bioidentical hormones. , The case study centers around a ... himself beginning to feel the effects of age-related hormonal decline. ...
(Date:7/25/2014)... July 25, 2014 A federal judge ... in two DePuy Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ... the claims to go before a jury on September ... rendered on July 18th, U.S. District Judge Ed Kinkeade ... two Plaintiffs’ claims may proceed to trial against Johnson ...
Breaking Medicine News(10 mins):Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 2Health News:Metabolic Enhancement Training Review Exposes Scott Abel's Program for Bodybuilding – Vkool.com 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
... NEW YORK, March 25 As Americans get ... it,s important for men with type 2,diabetes to ... low testosterone than,non-diabetic men., Listen to this ... Registered journalists can access video, audio, text, graphics ...
... In a ceremony,attended by Ohio,s physician leaders, ... of the most sweeping physician-insurance industry,contract reform bills ... law, which will take effect in ninety days, ... the contracting process,fairness in contracting, and a standardized ...
... of a prevention effort , , TUESDAY, March 25 (HealthDay ... to prevent cancer can often be overstated in certain ... a new report claims. , The review, published in ... of the National Cancer Institute , suggests that some ...
... A new study reviewing 75 group-randomized cancer trials over ... those studies used appropriate statistical methods to analyze the ... reported that interventions to prevent disease or reduce cancer ... have been. , More than a third of the ...
... NEW YORK, March 25 North American Insurance,Leaders, Inc. ... of a majority,of the common stock of NAO entitled ... voted against the proposal to consummate a business,combination, as ... Since NAO will not be able to complete ...
... China, March 25 /Xinhua-PRNewswire/ -- China Medicine,Corporation ... "the Company"),a leading developer and distributor of ... medicines (TCM), nutritional and,dietary supplements, medical devices, ... conduct a conference call at 9:00 a.m. ...
Cached Medicine News:Health News:Governor Strickland Signs House Bill 125 Into Law 2Health News:Some Cancer Trials Overstate Findings, Analysis Claims 2Health News:Some Cancer Trials Overstate Findings, Analysis Claims 3Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 2Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 3Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 3
(Date:7/24/2014)...   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... for Zalviso remains July 27, 2014.  The ... the Food and Drug Administration (FDA) had approved Zalviso.  ... notification to the company from the FDA regarding the ...
(Date:7/24/2014)... , Germany , and ... , Exclusive global license from ... SF3B1 mutations, including next-generation sequencing (NGS) gene panels, for ... be targeted by new test, indicate favorable prognosis for ... QIAGEN sees potential for developing companion diagnostics ...
(Date:7/24/2014)... Amgen (NASDAQ: AMGN ) today announced ... Tuesday, July 29, 2014, after the close of the U.S. ... call with the investment community at 2 p.m. PT. Participating ... Bradway , chairman and chief executive officer, and other members ... the conference call will be simultaneously broadcast over the Internet ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
... EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany , ... for filing the New Drug Application (NDA) for Cladribine Tablets as a ... , , ... Review designation by the FDA, which means the review period for the ...
... , SHANGHAI , July ... WX ) today announced that RiskMetrics Group,s ISS Proxy Advisory ... has recommended that WuXi shareholders vote FOR Charles River,s proposed,acquisition ... Proxy,Governance, previously recommended that WuXi shareholders vote FOR the,transaction. , ...
Cached Medicine Technology:EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 2EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 3EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 4EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 5ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 2ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 3ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 4ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 5
The Volk 30D is designed to provide the practitioner a wide field of view with a short working distance. This lens is excellent for use with small pupils....
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
... The Macula Plus® ... detailed observation of the ... macula. Use it with ... for detecting choroidal neovascular ...
... Iris Diagnostics iQ200 Sprint Automated Urine Microscopy ... to the iQ200 Series. The analyzer uses ... to classify urine particles into 12 categories ... eliminates most technologist time used to prepare ...
Medicine Products: